Skip to main content

Benkowitz Michael's Form 4 filing

United Therapeutics CorpUTHR · filed Oct 7, 2025

Accession no.
0001673232-25-000006
Filed
Oct 7, 2025
Trade date
Oct 6, 2025
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 12 non-derivative transactions and 2 derivative transactions. Open-market sales total $10.1M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Benkowitz MichaelCIK 0001673232Officer (PRESIDENT AND COO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 6, 2025Common StockMOption exerciseAcquired+14,625$135.42+$1,980,517.514,625Indirect
Oct 6, 2025Common StockSSaleDisposed−400$449.82F3−$179,92814,225Indirect
Oct 6, 2025Common StockSSaleDisposed−800$450.97F4−$360,77613,425Indirect
Oct 6, 2025Common StockSSaleDisposed−11,975$452.03F5−$5,413,059.251,450Indirect
Oct 6, 2025Common StockSSaleDisposed−1,250$453.16F6−$566,450200Indirect
Oct 6, 2025Common StockSSaleDisposed−200$253.98−$50,7960Indirect
Oct 6, 2025Common StockMOption exerciseAcquired+7,875$146.03+$1,149,986.257,875Indirect
Oct 6, 2025Common StockSSaleDisposed−300$450.06F8−$135,0187,575Indirect
Oct 6, 2025Common StockSSaleDisposed−500$451.01F9−$225,5057,075Indirect
Oct 6, 2025Common StockSSaleDisposed−6,625$452.04F10−$2,994,765450Indirect
Oct 6, 2025Common StockSSaleDisposed−350$453.51F11−$158,728.5100Indirect
Oct 6, 2025Common StockSSaleDisposed−100$454.81−$45,4810Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 6, 2025Common StockMOption exerciseDisposed−14,325$0.00$099,750Indirect
Oct 6, 2025Common StockMOption exerciseDisposed−7,875$0.00$017,500Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

This transaction was executed in multiple trades at prices ranging from $449.45 to $450.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $450.70 to $451.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $451.79 to $452.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $452.82 to $453.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F8

This transaction was executed in multiple trades at prices ranging from $449.58 to $450.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $450.70 to $451.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F10

This transaction was executed in multiple trades at prices ranging from $451.80 to $452.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F11

This transaction was executed in multiple trades at prices ranging from $453.13 to $454.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)